Rising ESRD population, improving treatment will spur revenue gains
Cleveland OH, August 21, 2023 — US kidney dialysis center revenues are forecast to advance 5.2% per year in nominal dollars through 2027, according to Kidney Dialysis Centers: United States
, a report recently released by Freedonia Focus Reports. Advances will reflect growth in the end-stage renal disease (ESRD) population, a consequence of the graying of the US population. In addition, providers will benefit from reduction in patient mortality as treatment quality improves. Faster advances in value terms will be restrained by ongoing government healthcare cost-containment efforts. Increasing awareness and use of donor exchange programs, which will boost transplantation rates, will also restrain growth in dialysis demand. Advances will also be restrained by the long-term effects of the July 2019 Advancing American Kidney Health executive order, which aims to prevent ESRD, encourage a shift from center- to home-based care, and boost transplant rates. In addition, the Health Resources & Services Administration announced the Organ Procurement and Transplantation Network Modernization Initiative in March 2023, which includes a doubling in government investment in organ procurement and transplantation. The initiative is in the design and strategy development phase as of summer 2023, with implementation expected to begin in spring 2024.
These and other key insights are featured in Kidney Dialysis Centers: United States. This report provides annual forecasts to 2027 for US kidney dialysis center revenues in nominal US dollars. Annual forecasts to 2027 are also provided for total population, point-prevalence of ESRD, and treatment modalities.
Total revenues are segmented by source in terms of:
- patient care
- private insurance
- other sources, such as charitable contributions, gifts, and grants
- non-patient care and other sources, such as administrative services, incentive fees, management fees, and medical director fees
Total population and point-prevalence of ESRD are segmented by age cohort as follows:
Point-prevalence of ESRD is also segmented by treatment modality as follows:
- peritoneal dialysis
To illustrate historical trends, total revenue, population, ESRD prevalence, and the various segments are provided in annual series from 2012 to 2022.
More information about the report is available at:
About Freedonia Focus Reports
Each month, The Freedonia Group – a division of MarketResearch.com – publishes over 20 new or updated Freedonia Focus Reports, providing fresh, unbiased analysis on a wide variety of markets and industries. Published in 20-30 pages, Focus Report coverage ranges from raw materials to finished manufactured goods and related services such as freight and construction. Additional Healthcare & Life Sciences
reports can be purchased at Freedonia Focus Reports
Analysis is intended to guide the busy reader through pertinent topics in rapid succession, including:
- total historical market size and industry output
- segmentation by products and markets
- identification of market drivers, constraints, and key indicators
- segment-by-segment outlook in five-year forecasts
- a survey of the supply base
- suggested resources for further study